Clinical Trials · NCT00608023
TH9507 Extension Study in Patients With HIV-Associated Lipodystrophy
- Phase
- Phase 3
- Recruitment status
- Completed
- Sponsor
- Theratechnologies
- Enrollment
- 263
- Start date
- Aug 2007
- Locations
- 47 sites, 6 countries
- Primary endpoint
- Changes From Baseline in Fasting Blood Glucose at Week 52